Susan E Yount1, Jennifer L Beaumont2, Shih-Yin Chen3, Karen Kaiser2, Katy Wortman2, David L Van Brunt3, Jeffrey Swigris4, David Cella2. 1. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N. Michigan Avenue, 27th Floor, Chicago, IL, 60611, USA. s-yount@northwestern.edu. 2. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N. Michigan Avenue, 27th Floor, Chicago, IL, 60611, USA. 3. Biogen, 225 Binney Street, Cambridge, MA, 02142, USA. 4. Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, 1400 Jackson Street, Denver, CO, 80206, USA.
Abstract
PURPOSE: Idiopathic pulmonary fibrosis (IPF) produces symptoms and activity limitations that impair health-related quality of life (HRQOL). The Patient-Reported Outcomes Measurement Information System(®) (PROMIS(®)) includes measures of self-reported health and HRQOL for a range of conditions. This study evaluated the HRQOL of individuals with IPF using PROMIS measures and examined associations between HRQOL and key symptoms or supplemental oxygen need. METHODS: Individuals who reported being told by a doctor that they have IPF completed an online battery of measures at baseline and 7-10 days later (for test-retest reliability). Measures included a brief survey of demographic and health-related questions, the PROMIS-29 profile, the Modified Medical Research Council Dyspnea Scale (MMRC), PROMIS dyspnea severity short form, A Tool to Assess Quality of life in IPF (ATAQ-IPF) and one cough item from the Functional Assessment of Chronic Illness Therapy (FACIT). RESULTS: 220 individuals were included in the final sample. Except for sleep disturbance, all PROMIS domain scores significantly (p < .01) differed by MMRC level. Supplemental oxygen users were more impaired than non-users in fatigue, physical function, and social role participation (p < 0.01). The test-retest reliability was acceptable to excellent (>0.7) for all scales, but was lower for sleep disturbance (0.64). CONCLUSIONS: People with IPF report substantial deficits in HRQOL across a range of PROMIS domains, and deficits vary by dyspnea and cough severity. These deficits warrant monitoring in clinical practice and consideration when investigating new therapies. Further research is required to further evaluate the psychometric performance of the PROMIS-29 in IPF.
PURPOSE:Idiopathic pulmonary fibrosis (IPF) produces symptoms and activity limitations that impair health-related quality of life (HRQOL). The Patient-Reported Outcomes Measurement Information System(®) (PROMIS(®)) includes measures of self-reported health and HRQOL for a range of conditions. This study evaluated the HRQOL of individuals with IPF using PROMIS measures and examined associations between HRQOL and key symptoms or supplemental oxygen need. METHODS: Individuals who reported being told by a doctor that they have IPF completed an online battery of measures at baseline and 7-10 days later (for test-retest reliability). Measures included a brief survey of demographic and health-related questions, the PROMIS-29 profile, the Modified Medical Research Council Dyspnea Scale (MMRC), PROMIS dyspnea severity short form, A Tool to Assess Quality of life in IPF (ATAQ-IPF) and one cough item from the Functional Assessment of Chronic Illness Therapy (FACIT). RESULTS: 220 individuals were included in the final sample. Except for sleep disturbance, all PROMIS domain scores significantly (p < .01) differed by MMRC level. Supplemental oxygen users were more impaired than non-users in fatigue, physical function, and social role participation (p < 0.01). The test-retest reliability was acceptable to excellent (>0.7) for all scales, but was lower for sleep disturbance (0.64). CONCLUSIONS:People with IPF report substantial deficits in HRQOL across a range of PROMIS domains, and deficits vary by dyspnea and cough severity. These deficits warrant monitoring in clinical practice and consideration when investigating new therapies. Further research is required to further evaluate the psychometric performance of the PROMIS-29 in IPF.
Entities:
Keywords:
Health-related quality of life; Idiopathic pulmonary fibrosis; PROMIS
Authors: Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster Journal: Am J Respir Crit Care Med Date: 2006-06-29 Impact factor: 21.405
Authors: Honghu Liu; David Cella; Richard Gershon; Jie Shen; Leo S Morales; William Riley; Ron D Hays Journal: J Clin Epidemiol Date: 2010-08-05 Impact factor: 6.437
Authors: Monique Hinchcliff; Jennifer L Beaumont; Krishna Thavarajah; John Varga; Anh Chung; Sofia Podlusky; Mary Carns; Rowland W Chang; David Cella Journal: Arthritis Care Res (Hoboken) Date: 2011-11 Impact factor: 4.794
Authors: Susan E Yount; Seung W Choi; David Victorson; Bernice Ruo; David Cella; Susan Anton; Alan Hamilton Journal: Value Health Date: 2011 Mar-Apr Impact factor: 5.725
Authors: Benjamin D Schalet; Paul A Pilkonis; Lan Yu; Nathan Dodds; Kelly L Johnston; Susan Yount; William Riley; David Cella Journal: J Clin Epidemiol Date: 2016-02-27 Impact factor: 6.437
Authors: Fang-Ju Lin; A Simon Pickard; Jerry A Krishnan; Min J Joo; David H Au; Shannon S Carson; Suzanne Gillespie; Ashley G Henderson; Peter K Lindenauer; Mary Ann McBurnie; Richard A Mularski; Edward T Naureckas; William M Vollmer; Todd A Lee Journal: BMC Med Res Methodol Date: 2014-06-16 Impact factor: 4.615
Authors: Felix Fischer; Chris Gibbons; Joël Coste; Jose M Valderas; Matthias Rose; Alain Leplège Journal: Qual Life Res Date: 2018-01-19 Impact factor: 4.147
Authors: Jonathan Savitz; Bart N Ford; Hung-Wen Yeh; Elisabeth Akeman; Kelly Cosgrove; Ashley N Clausen; Christopher Martell; Namik Kirlic; Jessica Santiago; T Kent Teague; Michael R Irwin; Martin P Paulus; Robin L Aupperle Journal: Psychol Med Date: 2020-11-25 Impact factor: 10.592
Authors: Michael Kreuter; Jeff Swigris; David Pittrow; Silke Geier; Jens Klotsche; Antje Prasse; Hubert Wirtz; Dirk Koschel; Stefan Andreas; Martin Claussen; Christian Grohé; Henrike Wilkens; Lars Hagmeyer; Dirk Skowasch; Joachim F Meyer; Joachim Kirschner; Sven Gläser; Felix J F Herth; Tobias Welte; Claus Neurohr; Martin Schwaiblmair; Matthias Held; Thomas Bahmer; Marion Frankenberger; Jürgen Behr Journal: Respir Res Date: 2017-07-14